🇺🇸 FDA
Pipeline program

HB-adMSC

HBCOV03

Phase 2 mab terminated

Quick answer

HB-adMSC for COVID-19 is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
COVID-19
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials